EssilorLuxottica receives FDA clearance and EU certifications for Nuance Audio, making it available to consumers in the U.S. and Europe
Werte in diesem Artikel
EssilorLuxottica receives FDA clearance and EU certifications for Nuance Audio, making it available to consumers in the U.S. and Europe
Paris, France (3 February 2025) – EssilorLuxottica announced today that it has received clearance from the Food and Drug Administration (FDA) for its OTC Nuance Audio Glasses. The Group has simultaneously achieved the CE marking under the Medical Devices Regulation in the EU, alongside the development of an ISO Quality Management System certification dedicated to Hearing Aids, which will allow Nuance Audio to launch in Europe.
Paving the way for a disruptive new category in the med-tech space, Nuance Audio Hearing Aid Software is the first FDA cleared, preset Software as Medical Device (SaMD) in the U.S. It delivers a groundbreaking open-ear hearing solution seamlessly integrated into a pair of stylish smart glasses. After decades of adoption barriers ranging from comfort to visibility, consumers will finally be able to see clearly and hear clearly with a single product that is both beautiful and highly functional.
Nuance Audio will be available for purchase in the U.S. beginning in Q1. In the first half of 2025, it will be available in certain European countries, including France, Germany and UK, starting progressively from Italy in Q1, in parallel with U.S. market.
As part of EssilorLuxottica ’s open business model, the Group will leverage its extensive retail network, while also engaging both traditional audiology practices and optical wholesale customers to make this technology accessible to consumers wherever possible.
"Two years ago, we set out to create a first-of-its-kind product that would change the way people see and hear. We didn’t just aim to combine two medical devices – we created an entirely new smart glasses form factor to support the two human senses we depend on the most. It is not only groundbreaking, but also incredibly accessible. We’re pleased now to turn our focus to getting this life-changing technology into the hands of people around the world who truly need it,” said Francesco Milleri, Chairman and CEO of EssilorLuxottica.
The global hearing solutions market remains underserved, much like the vision market decades ago, where consumers are often hesitant to wear corrective devices due to factors such as stigma, discomfort, cost, and limited accessibility. Nuance Audio seeks to overcome these barriers, which have hindered the widespread adoption of traditional hearing aids. With the introduction of Nuance Audio Glasses, the company aims to meet the needs of approximately 1.25 billion1 people worldwide who experience mild to moderate hearing loss.
Notes:
1 World Health Organization, World Report on Hearing, 2021, p. 40.
Attachment
Ausgewählte Hebelprodukte auf EssilorLuxottica
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf EssilorLuxottica
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu EssilorLuxottica
Analysen zu EssilorLuxottica
Datum | Rating | Analyst | |
---|---|---|---|
30.01.2025 | EssilorLuxottica Neutral | UBS AG | |
29.01.2025 | EssilorLuxottica Outperform | RBC Capital Markets | |
22.01.2025 | EssilorLuxottica Buy | Goldman Sachs Group Inc. | |
16.01.2025 | EssilorLuxottica Buy | Goldman Sachs Group Inc. | |
09.01.2025 | EssilorLuxottica Kaufen | DZ BANK |
Datum | Rating | Analyst | |
---|---|---|---|
29.01.2025 | EssilorLuxottica Outperform | RBC Capital Markets | |
22.01.2025 | EssilorLuxottica Buy | Goldman Sachs Group Inc. | |
16.01.2025 | EssilorLuxottica Buy | Goldman Sachs Group Inc. | |
09.01.2025 | EssilorLuxottica Kaufen | DZ BANK | |
12.12.2024 | EssilorLuxottica Buy | Goldman Sachs Group Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
30.01.2025 | EssilorLuxottica Neutral | UBS AG | |
09.01.2025 | EssilorLuxottica Sector Perform | RBC Capital Markets | |
02.01.2025 | EssilorLuxottica Neutral | UBS AG | |
12.12.2024 | EssilorLuxottica Sector Perform | RBC Capital Markets | |
11.12.2024 | EssilorLuxottica Neutral | UBS AG |
Datum | Rating | Analyst | |
---|---|---|---|
15.02.2024 | EssilorLuxottica Verkaufen | DZ BANK | |
01.09.2023 | EssilorLuxottica Underperform | RBC Capital Markets | |
26.07.2023 | EssilorLuxottica Underperform | RBC Capital Markets | |
29.06.2023 | EssilorLuxottica Underperform | RBC Capital Markets | |
17.05.2023 | EssilorLuxottica Underperform | RBC Capital Markets |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für EssilorLuxottica nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen